Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Peters

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Oncology Reports|February 20, 2014
GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinomaInga Peters, Kai Gebauer, Natalia Dubrowinskaja, et al.
Frontiers in Oncology|June 13, 2020
Checkpoint Inhibition for Metastatic Urothelial Carcinoma After Chemotherapy-Real-World Clinical Impressions and Comparative Review of the LiteratureChristian Fuhrmann, Julian P Struck, Philipp Ivanyi, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 23, 2015
Genome-wide association study of schizophrenia in Ashkenazi JewsFernando S Goes, John McGrath, Dimitrios Avramopoulos, et al.
International Journal of Cancer|January 25, 2022
A randomized trial of risk-adapted screening for prostate cancer in young men-Results of the first screening round of the PROBASE trialChristian Arsov, Peter Albers, Kathleen Herkommer, et al.
Plos One|August 12, 2022
Combination of PI-RADS score and mRNA urine test-A novel scoring system for improved detection of prostate cancerOlga Katzendorn, Christoph A J von Klot, Samy Mahjoub, et al.
International Journal of Cancer|September 19, 2022
Adherence to a risk-adapted screening strategy for prostate cancer: First results of the PROBASE trialAgne Krilaviciute, Peter Albers, Jale Lakes, et al.
World Journal of Urology|April 3, 2014
Is there an anti-androgen withdrawal syndrome for enzalutamide?Christoph A J von Klot, Mario W Kramer, Alena Böker, et al.
European Urology Oncology|October 8, 2023
Digital Rectal Examination Is Not a Useful Screening Test for Prostate CancerAgne Krilaviciute, Nikolaus Becker, Jale Lakes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 5, 2021
Predictors for the utilization of social service counseling by prostate cancer patientsClara Breidenbach, Lena Ansmann, Nora Tabea Sibert, et al.
Plos One|September 15, 2020
To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemicNina N Harke, Jan P Radtke, Boris A Hadaschik, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Oncology Reports|February 20, 2014
GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinomaInga Peters, Kai Gebauer, Natalia Dubrowinskaja, et al.
Frontiers in Oncology|June 13, 2020
Checkpoint Inhibition for Metastatic Urothelial Carcinoma After Chemotherapy-Real-World Clinical Impressions and Comparative Review of the LiteratureChristian Fuhrmann, Julian P Struck, Philipp Ivanyi, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 23, 2015
Genome-wide association study of schizophrenia in Ashkenazi JewsFernando S Goes, John McGrath, Dimitrios Avramopoulos, et al.
International Journal of Cancer|January 25, 2022
A randomized trial of risk-adapted screening for prostate cancer in young men-Results of the first screening round of the PROBASE trialChristian Arsov, Peter Albers, Kathleen Herkommer, et al.
Plos One|August 12, 2022
Combination of PI-RADS score and mRNA urine test-A novel scoring system for improved detection of prostate cancerOlga Katzendorn, Christoph A J von Klot, Samy Mahjoub, et al.
International Journal of Cancer|September 19, 2022
Adherence to a risk-adapted screening strategy for prostate cancer: First results of the PROBASE trialAgne Krilaviciute, Peter Albers, Jale Lakes, et al.
World Journal of Urology|April 3, 2014
Is there an anti-androgen withdrawal syndrome for enzalutamide?Christoph A J von Klot, Mario W Kramer, Alena Böker, et al.
European Urology Oncology|October 8, 2023
Digital Rectal Examination Is Not a Useful Screening Test for Prostate CancerAgne Krilaviciute, Nikolaus Becker, Jale Lakes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 5, 2021
Predictors for the utilization of social service counseling by prostate cancer patientsClara Breidenbach, Lena Ansmann, Nora Tabea Sibert, et al.
Plos One|September 15, 2020
To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemicNina N Harke, Jan P Radtke, Boris A Hadaschik, et al.
Pageof 6